| Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases |
97 |
| Glycosylation in health and disease |
96 |
| Global epidemiology and outcomes of acute kidney injury |
90 |
| The Klotho proteins in health and disease |
67 |
| Pre-eclampsia: pathogenesis, novel diagnostics and therapies |
66 |
| Macrophages: versatile players in renal inflammation and fibrosis |
65 |
| Cellular signalling by primary cilia in development, organ function and disease |
64 |
| Advances in the understanding and treatment of sepsis-induced immunosuppression |
62 |
| The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group |
58 |
| CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease |
57 |
| The renaissance of complement therapeutics |
56 |
| The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease |
53 |
| Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease |
53 |
| Obesity, kidney dysfunction and hypertension: mechanistic links |
47 |
| Mechanisms and treatment of organ failure in sepsis |
46 |
| Angiotensin-converting enzyme in innate and adaptive immunity |
45 |
| Mitochondrial dysfunction in diabetic kidney disease |
44 |
| Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia |
44 |
| Paradigms of acute kidney injury in the intensive care setting |
41 |
| C3 glomerulopathy - understanding a rare complement-driven renal disease |
40 |
| Single-cell RNA sequencing for the study of development, physiology and disease |
38 |
| The role of inflammasomes in kidney disease |
38 |
| Environmental pollution and kidney diseases |
37 |
| Endothelium structure and function in kidney health and disease |
34 |
| Sex-specific differences in hypertension and associated cardiovascular disease |
30 |
| The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD |
30 |
| Epigenetics and epigenomics in diabetic kidney disease and metabolic memory |
29 |
| Metabolism and mitochondria in polycystic kidney disease research and therapy |
27 |
| Dyslipidaemia in nephrotic syndrome: mechanisms and treatment |
26 |
| Lipid management in patients with chronic kidney disease |
25 |
| Estimated GFR: time for a critical appraisal |
25 |
| Extracellular DNA traps in inflammation, injury and healing |
24 |
| Renal and extrarenal effects of fibroblast growth factor 23 |
22 |
| Intestinal microbiome and fitness in kidney disease |
21 |
| Mechanisms of hypoxia signalling: new implications for nephrology |
21 |
| Cardiorenal complications of immune checkpoint inhibitors |
20 |
| Genomic medicine for kidney disease |
20 |
| Pericytes in the renal vasculature: roles in health and disease |
20 |
| Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications |
20 |
| Novel treatment strategies for chronic kidney disease: insights from the animal kingdom |
19 |
| Immune mechanisms of salt-sensitive hypertension and renal end-organ damage |
19 |
| The neural basis of homeostatic and anticipatory thirst |
19 |
| Cancer in kidney transplant recipients |
19 |
| Intravenous fluid therapy in critically ill adults |
18 |
| Haemodialysis membranes |
18 |
| Effector and regulatory B cells in immune-mediated kidney disease |
18 |
| Modelling diabetic nephropathy in mice |
18 |
| Mechanisms of phosphate transport |
17 |
| The (pro)renin receptor in health and disease |
17 |
| The genetic changes of Wilms tumour |
17 |
| Immunologic and endocrine functions of adipose tissue: implications for kidney disease |
16 |
| Advances in predictive in vitro models of drug-induced nephrotoxicity |
16 |
| The ubiquitin-proteasome system in kidney physiology and disease |
16 |
| Human kidney organoids: progress and remaining challenges |
16 |
| Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction |
14 |
| Circadian rhythms and the kidney |
14 |
| HLA in transplantation |
14 |
| Reproductive health and pregnancy in women with chronic kidney disease |
14 |
| Evolving concepts in the pathogenesis of uraemic cardiomyopathy |
14 |
| Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling |
14 |
| Immunity, microbiota and kidney disease |
13 |
| Mechanisms of haemolysis-induced kidney injury |
12 |
| Central nervous system neuroplasticity and the sensitization of hypertension |
12 |
| Renal disease in tuberous sclerosis complex: pathogenesis and therapy |
12 |
| International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people |
12 |
| Molecular nephrology: types of acute tubular injury |
12 |
| The pathobiology of polycystic kidney disease from a metabolic viewpoint |
11 |
| Antimicrobial resistance in nephrology |
11 |
| Precision gene editing technology and applications in nephrology |
11 |
| The multifaceted role of complement in kidney transplantation |
10 |
| The adjuvant treatment of kidney cancer: a multidisciplinary outlook |
10 |
| Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease |
10 |
| Molecular stratification of idiopathic nephrotic syndrome |
9 |
| Hepatitis C virus and the kidney |
9 |
| Renin cells in homeostasis, regeneration and immune defence mechanisms |
8 |
| The role of sodium in modulating immune cell function |
8 |
| Sex and the kidneys: current understanding and research opportunities |
7 |
| The role of platelets in acute kidney injury |
7 |
| Structure and function of polycystins: insights into polycystic kidney disease |
7 |
| Immunology of the ageing kidney |
7 |
| Maternal and environmental risk factors for neonatal AKI and its long-term consequences |
6 |
| Animal models of monoclonal immunoglobulin-related renal diseases |
6 |
| HLA and kidney disease: from associations to mechanisms |
5 |
| The role of B7-1 in proteinuria of glomerular origin |
4 |
| Diagnosis and management of resistant hypertension: state of the art |
4 |
| Kidneys and women's health: key challenges and considerations |
0 |
